Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
135 studies found for:    "Lipodystrophy"
Show Display Options
Rank Status Study
1 Unknown  Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
Condition: Lipodystrophy
Intervention: Procedure: autologous transplantation of liposuction material enriched with adipose-derived stem cells
2 Recruiting Lipodystrophy Connect Patient Registry
Condition: Lipodystrophy
Intervention:
3 Recruiting Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Condition: Lipodystrophy
Interventions: Drug: ISIS 304801;   Drug: Placebo
4 Completed Identification of a New Gene Involved in Hereditary Lipodystrophy
Condition: Lipodystrophy
Interventions: Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene;   Biological: Perform blood cells and fibroblasts biochemical and immuno-labeled investigations
5 Completed Corticosteroid-induced Lipodystrophy and Adipokines
Condition: Lipodystrophy
Intervention: Other: Samples and procedures
6 Completed
Has Results
Leptin to Treat Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: Metreleptin
7 Recruiting Short-term Effects of Leptin in People With Lipodystrophy
Condition: Lipodystrophy
Intervention: Biological: Metreleptin
8 Completed Leptin to Treat Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: hu Leptin (A-100)
9 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
10 Completed
Has Results
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Condition: HIV Lipodystrophy
Interventions: Drug: Human recombinant leptin ("metreleptin");   Drug: Placebo
11 Recruiting Familial Partial Lipodystrophy Study
Condition: Lipodystrophy, Familial Partial
Intervention: Other: High fat mixed meal
12 Recruiting Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Condition: Familial Partial Lipodystrophy
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
13 Completed An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: metreleptin
14 Recruiting The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy
Condition: Familial Partial Lipodystrophy
Interventions: Drug: volanesorsen;   Drug: Placebo
15 Completed Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Condition: HIV-Associated Lipodystrophy Syndrome
Intervention:
16 Completed
Has Results
Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs);   Drug: continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)
17 Not yet recruiting Post Authorisation Safety Registry for US Patients With Generalised Lipodystrophy Treated With Metreleptin
Condition: Generalised Lipodystrophy
Intervention:
18 Completed Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
19 Completed Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Device: Newfill;   Device: Eutrophill
20 Unknown  Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
Condition: HAART-induced Lipodystrophy and Metabolic Syndrome
Intervention: Drug: r-metHuLeptin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.